Concepedia

Phase I/II Trial of Nanomolecular Liposomal Annamycin in Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia

Meir Wetzler, D. A. Thomas, Eunice S. Wang, Robert Shepard, Laurie Ford, Thompson L. Heffner, Samir Parekh, Michael Andreeff, Susan O’Brien, Hagop M. Kantarjian

Clinical Lymphoma Myeloma & Leukemia · 2013 · 45 citations · 13 references

DOIFull text

Open access

Concepts

References

13

Results of Treatment With Hyper-CVAD, a Dose-Intensive Regimen, in Adult Acute Lymphocytic Leukemia

Hagop M. Kantarjian, Susan O’Brien, Terry L. Smith et al. · Journal of Clinical Oncology · 2000 · 795 citations

, , +15

Chemoimmunotherapy With a Modified Hyper-CVAD and Rituximab Regimen Improves Outcome in De Novo Philadelphia Chromosome–Negative Precursor B-Lineage Acute Lymphoblastic Leukemia

Deborah A. Thomas, Susan O’Brien, Stefan Faderl et al. · Journal of Clinical Oncology · 2010 · 412 citations · Full text

, , +17

Effective asparagine depletion with pegylated asparaginase results in improved outcomes in adult acute lymphoblastic leukemia: Cancer and Leukemia Group B Study 9511

Meir Wetzler, Ben L. Sanford, Joanne Kurtzberg et al. · Blood · 2007 · 202 citations · Full text

, , +9

Pharmacodynamics and safety of intravenous pegaspargase during remission induction in adults aged 55 years or younger with newly diagnosed acute lymphoblastic leukemia

Dan Douer, Henry Yampolsky, Lewis Cohen et al. · Blood · 2006 · 169 citations

, , +7

MDR1 protein expression is an independent predictor of complete remission in newly diagnosed adult acute lymphoblastic leukemia

Agostino Tafuri · Blood · 2002 · 111 citations · Full text

, , +8